Jeffrey Greve

No open positions remaining

Health Technology

Consumer Services

Profile

Jeffrey Greve is the founder of Delinia, Inc. (founded in 2015) and Kyverna Therapeutics, Inc. (founded in 2018).
At Delinia, he held the title of Chief Scientific Officer.
At Kyverna Therapeutics, he held the title of Chief Scientific Officer from 2018 to 2022.
Dr. Greve's former job was as Vice President-Research at aTyr Pharma, Inc. Dr. Greve earned a doctorate degree from the University of Washington and an undergraduate degree from The Johns Hopkins University.

Former positions of Jeffrey Greve

Companies	Position	End
KYVERNA THERAPEUTICS, INC.	Founder	22/08/2022
Delinia, Inc. Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases	Founder	-
ATYR PHARMA, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Jeffrey Greve's experience

Training of Jeffrey Greve

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Greve's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
aTyr Pharma, Inc. aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways	Health Technology
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Delinia, Inc. Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases	Health Technology
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases	Health Technology